• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YANG Liu,HE Yan,HU Yuxi,XU Zhenyu.Interpretation of “Guidance on Polymorphism Study of Chemical Generic Drugs(Trial)”[J].Journal Of Pharmaceutical Research,2024,43(6):564-567[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3326times   Download 2847次 QR Code for this article
Scan with your phone!
《化学仿制药晶型研究技术指导原则(试行)》解读
杨柳,何艳,胡玉玺,许真玉
Font:Larger+|Default|Smaller-
(国家药品监督管理局药品审评中心,北京 100022)
摘要:
近年来,药物的晶型研究已成为国际药学领域的研究热点,为鼓励和促进国内制药企业的化学仿制药发展,明确化学仿制药研发过程中晶型研究的关注点,国家药品监督管理局药品审评中心于 2022 年 1月4日正式发布了《化学仿制药晶型研究技术指导原则(试行)》。本文结合该指导原则的起草背景,充分考虑仿制药开发的特点,对指导原则内容和重点问题进行详细解读,以供业界更好的理解和运用。
关键词:  化学仿制药  晶型研究  技术指南  解读
DOI:10.13506/j.cnki.jpr.2024.06.008
基金项目:
Publication Date:June 25, 2024
Interpretation of “Guidance on Polymorphism Study of Chemical Generic Drugs(Trial)”
YANG Liu,HE Yan,HU Yuxi,XU Zhenyu
(Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China)
Abstract:
In recent years, polymorphism study of chemical drugs has become a research hotspot in the international pharmaceutical field, in order to encourage and promote the development of chemical generic drugs in domestic pharmaceutical enterprises, and clarify the focus of crystal research in the process of chemical generic drug research and development, the Center for Drug Evaluation of National Medical Products Administration officially issued the " Guideline on Polymorphism Study of Chemical Generic Drugs" on January 4, 2022. A detailed interpretation of the guidance is provided in this paper,combined with the drafting process of the guidance and fully considering the characteristics of generic drug development,in order to help applicants to get a better understanding and application.
Key words:  Chemical generic drugs  Polymorphism  Guidance  Interpretation
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.